Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TECH

+ Watchlist+ Portfolio

Bio-Techne Corp

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$72.75
52-Week Range
$43.20 – $72.88
Market Cap
$11.42B
P/E (TTM)
66.70
EPS (TTM)
1.09
Dividend Yield
0.44%
Advanced Metrics
Price/Book
5.27
PEG Ratio
2.17
Return on Equity
8.33%
Return on Assets
6.45%
Gross Margin
66.17%
Operating Margin
21.69%
Profit Margin
14.00%
Current Ratio
2.28
Debt/Equity
0.13
Total Debt
$285.56M
Free Cash Flow
$277.76M
Revenue Growth
4.60%
Earnings Growth
-25.00%
Enterprise Value
$11.35B

Market Snapshot

About

Bio-Techne Corp. is a global life sciences company that develops and manufactures high-quality reagents, analytical instruments, and diagnostic products for the research and clinical diagnostic markets. The company serves biopharmaceutical, academic, and diagnostic customers worldwide. Bio-Techne operates through two segments: Protein Sciences and Diagnostics and Genomics.